Jae I. Zo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: January 21, 2025
Corrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system.
Journal: Frontiers in oncology
Published: October 04, 2024
Author Correction: Preoperative DLco and FEV1 are correlated with postoperative pulmonary complications in patients after esophagectomy.
Journal: Scientific reports
Published: April 02, 2024
Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study.
Journal: EClinicalMedicine
Published: October 14, 2023
Treatment Patterns and Outcomes of Anastomotic Leakage after Esophagectomy for Esophageal Cancer.
Journal: Journal of chest surgery
Published: August 18, 2023
Enhanced Recovery After Surgery Program and Opioid Consumption in Pulmonary Resection Surgery: A Retrospective Observational Study.
Journal: Anesthesia and analgesia
Published: February 08, 2023
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 01, 2022
The Role of Adjuvant Therapy Following Surgical Resection of Small Cell Lung Cancer: A Multi-Center Study.
Journal: Cancer research and treatment
Published: May 05, 2022
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 23, 2022
Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Journal: Annals of surgery
Published: February 15, 2022
Last Updated: 09/26/2026